Dare Bioscience develops women's health drugs and consumer products for areas such as contraception, menopause, and sexual health. DARE reports earnings on Thu, Nov 12, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 26 | Ladenburg Thalmann | Assumed coverage | Buy |
Seasonality
How DARE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.
Whale Options Flow
90DNo whale options trades in DARE in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DARE is in one of them and how their past DARE trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered DARE in an article yet. Here's the latest on the wider market.
About Dare Bioscience
Dare Bioscience is a biotech company based in San Diego, California, that develops products for women's health. Its portfolio covers areas such as contraception, menopause, sexual health, pelvic pain, fertility, and vaginal health. The company plans to offer prescription products, compounded drugs, and consumer health products that do not need a prescription, mainly for women and the healthcare providers who treat them. Its first FDA-approved product, a treatment for bacterial vaginosis, is licensed to another drugmaker for sale.
- Headquarters
- San Diego, CA